Xcout Intel
Phase Genomics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Phase Genomics, Inc. among biotechnology companies — ranked by similarity to what Phase Genomics, Inc. actually does, not by market-cap band.
Subscribe to see Phase Genomics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Phase Genomics, Inc.
Phase Genomics, Inc. is headquartered in Seattle, Washington, and provides ultra-long-range sequencing solutions and Hi-C technologies. The company supports genomic research and applications through its specialized laboratory products and services.
Phase Genomics, Inc. at a glance
Phase Genomics, Inc. is a biotechnology company headquartered in United States. It has raised at least $7.3M across the 3 funding rounds on record. Its most recent funding round, Grant, raised $1.5M in March 2024. Xcout tracks 3 named people at Phase Genomics, Inc., including Kayla Young (COO).
Phase Genomics, Inc. leadership
- Kayla YoungCOO
- Ivan LiachkoFounder & CEO
- Stephen EackerVP of Research & Development
Phase Genomics, Inc. funding rounds
At least $7.3M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | $1.5M | 4 named | |
| SEC Form D filing | $4.8M | — | |
| SEC Form D filing | $1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Phase Genomics, Inc. competitors
Ranked by semantic similarity — how close each company is to Phase Genomics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Paragon Genomics is a precision medicine company headquartered in Fremont, California. The company develops and commercializes patented targeted sequencing and breakthrough target enrichment solutions for researchers and clinical applications.
Similar biotechnology company
ArgenTAG Corporation is a biotechnology company specializing in high-resolution single-cell long-read sequencing solutions. Headquartered in New York, New York, the company develops innovative genomic tools for life sciences research.
Biotech
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
Similar biotechnology company
Pacific Biosciences of California, Inc. is a global life sciences technology company headquartered in Menlo Park, California, that develops genetic sequencing systems.
Similar biotechnology company
Arima Genomics is a biotechnology company headquartered in San Diego, California. The company leverages whole-genome sequence and three-dimensional genomic structure information to advance life science research and cancer therapy.
Biotech
Ultima Genomics is a company headquartered in Fremont, California, with 100-1000 employees. Its mission is to continuously drive the power of genomics, operating in the AI, Biotech/Pharma, and Life Sciences sectors.
Similar biotechnology company
Olink Proteomics provides high-throughput protein biomarker analysis products, instruments, software, and analysis services for life science research and drug development. Utilizing its proprietary Proximity Extension Assay (PEA) technology and next-generation sequencing, the company serves researchers and pharmaceutical organizations focused on biomarker discovery and precision medicine.
Biotech
Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analysis of structural variations in the genome using optical genome mapping. This technology is vital for deciphering genetic variations and their functional roles. The Saphyr platform includes the Saphyr instrument, a device capable of imaging single molecules; the Saphyr Chip, a disposable component equipped with nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide essential reagents and protocols for extracting and tagging ultra-high molecular weight DNA. Furthermore, Bionano Genomics supplies Saphyr and Bionano compute servers to support its analytical operations. It also offers NxClinical, a single software system designed for the analysis and interpretation of genomic variants identified through microarray and next-generation sequencing data, serving both cytogenetics and molecular genetics applications. In addition to its product line, Bionano Genomics delivers a variety of specialized testing and laboratory services. These include: FirstStepDx PLUS: A chromosomal microarray service used to identify underlying genetic causes in individuals with autism spectrum disorder, developmental delay, and intellectual disability. Fragile X syndrome (FXS) testing services: Comprehensive diagnostic testing for FXS. NextStepDx PLUS: An exome sequencing test aimed at detecting genetic variants associated with childhood developmental disorders. EpiPanelDx PLUS: A genetic testing panel for patients experiencing seizures, infantile spasms, encephalopathy, or febrile seizures. PGx test: A pharmacogenomics test that identifies over 60 alleles across 11 genes relevant to drug response. Bionano Genomics was founded in 2003 and operates from its corporate headquarters in San Diego, California.
Similar biotechnology company
Volta Labs is a biotechnology research company headquartered in Boston, Massachusetts. It has developed a cutting-edge sample preparation system to improve performance, scalability, and consistency in genomics applications.
Biotech
Illumina, Inc. specializes in delivering advanced sequencing and array technologies designed for genetic and genomic examination. These offerings cater to a diverse array of markets, fostering the widespread use of genomic insights across both research laboratories and clinical environments. Key application areas include life sciences, cancer diagnostics, reproductive medicine, agricultural science, and various nascent fields. The company's portfolio encompasses specialized instrumentation and associated consumables vital for genetic analysis. Additionally, it offers comprehensive genotyping and sequencing services, extends instrument maintenance contracts, and engages in development and licensing partnerships, alongside providing cancer screening services. Illumina's client base is extensive, comprising genomic research facilities, universities, state-funded laboratories, and healthcare providers. It also serves pharmaceutical firms, biotechnology companies, commercial molecular diagnostics providers, and businesses focused on consumer genomics. Globally, Illumina distributes its products through direct sales channels in North America, Europe, Latin America, and the Asia-Pacific. Furthermore, it leverages third-party life-science distributors to reach markets across Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
Biotech
Pixelgen Technologies is a Swedish life-sciences company developing spatial proteomics technology that maps the location and interactions of proteins in and around individual cells. Its tools are intended for academic, biopharmaceutical, and biomedical researchers studying cell biology, immunology, and disease mechanisms.
Similar biotechnology company
Molecular Loop Biosciences, Inc. is a genomics and targeted sequencing leader headquartered in Woburn, Massachusetts, founded in 2018 to advance molecular biology tools.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Phase Genomics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Phase Genomics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →